Drospirenone: pharmacology and pharmacokinetics of a unique progestogen

被引:297
作者
Krattenmacher, R [1 ]
机构
[1] Berlex Labs Inc, Wayne, NJ 07470 USA
关键词
drospirenone; progestogen; oral contraceptive; renin-angiotensin-aldosterone system; premenstrual syndrome;
D O I
10.1016/S0010-7824(00)00133-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The pharmacology and pharmacokinetics of drospirenone, a unique progestogen, are reviewed in this paper. Unlike other progestogens, drospirenone, an analogue of spironolactone, has biochemical and pharmacologic profiles similar to endogenous progesterone, especially regarding antimineralocorticoid and antiandrogenic activities. Drospirenone counteracts the estrogen-induced stimulation of the renin-angiotensin-aldosterone system and blocks testosterone from binding to androgen receptors. Because of these characteristics, it has the potential to reduce body weight, blood pressure, and low-density lipoprotein levels and to enhance high-density lipoprotein levels. As a combination oral contraceptive, drospirenone with ethinyl estradiol is effective and has positive effects on weight and lipid levels. Additionally, it relieves menstrually related symptoms (e.g., negative affect and water retention) that are commonly observed with other combination oral contraceptives. Based on the biochemical and pharmacodynamic data, drospirenone appears to be a viable alternative to the currently available progestogens. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:29 / 38
页数:10
相关论文
共 27 条
[11]   ISOLATION AND IDENTIFICATION OF SPIRORENONE METABOLITES FROM THE MONKEY (MACACA-FASCICULARIS) [J].
KRAUSE, W ;
KUHNE, G .
STEROIDS, 1982, 40 (01) :81-90
[12]   SYNTHESIS AND ACTIVITIES OF ANTI-ALDOSTERONES [J].
LAURENT, H ;
BITTLER, D ;
HOFMEISTER, H ;
NICKISCH, K ;
NICKOLSON, R ;
PETZOLDT, K ;
WIECHERT, R .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1983, 19 (01) :771-776
[13]   ATTENUATION OF MILD HYPERANDROGENIC ACTIVITY IN POSTPUBERTAL ACNE BY A TRIPHASIC ORAL-CONTRACEPTIVE CONTAINING LOW-DOSES OF ETHYNYL ESTRADIOL AND D,L-NORGESTREL [J].
LEMAY, A ;
DEWAILLY, SD ;
GRENIER, R ;
HUARD, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (01) :8-14
[14]  
LOSERT W, 1985, ARZNEIMITTELFORSCH, V35, P459
[15]   DEVELOPMENT OF A MENSTRUAL DISTRESS QUESTIONNAIRE [J].
MOOS, RH .
PSYCHOSOMATIC MEDICINE, 1968, 30 (06) :853-&
[16]   DROSPIRENONE - A NOVEL PROGESTOGEN WITH ANTIMINERALOCORTICOID AND ANTIANDROGENIC ACTIVITY [J].
MUHN, P ;
FUHRMANN, U ;
FRITZEMEIER, KH ;
KRATTENMACHER, R ;
SCHILLINGER, E .
STEROID RECEPTORS AND ANTIHORMONES, 1995, 761 :311-335
[17]   DROSPIRENONE - A NOVEL PROGESTOGEN WITH ANTIMINERALOCORTICOID AND ANTIANDROGENIC ACTIVITY [J].
MUHN, P ;
KRATTENMACHER, R ;
BEIER, S ;
ELGER, W ;
SCHILLINGER, E .
CONTRACEPTION, 1995, 51 (02) :99-110
[18]   DIHYDROSPIRORENONE, A NEW PROGESTOGEN WITH ANTIMINERALOCORTICOID ACTIVITY - EFFECTS ON OVULATION, ELECTROLYTE EXCRETION, AND THE RENIN-ALDOSTERONE SYSTEM IN NORMAL WOMEN [J].
OELKERS, W ;
BERGER, V ;
BOLIK, A ;
BAHR, V ;
HAZARD, B ;
BEIER, S ;
ELGER, W ;
HEITHECKER, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (04) :837-842
[19]   EFFECTS OF A NEW ORAL-CONTRACEPTIVE CONTAINING ARM ANTIMINERALOCORTICOID PROGESTOGEN, DROSPIRENONE, ON THE RENIN-ALDOSTERONE SYSTEM, BODY-WEIGHT, BLOOD-PRESSURE, GLUCOSE-TOLERANCE, AND LIPID-METABOLISM [J].
OELKERS, W ;
FOIDART, JM ;
DOMBROVICZ, N ;
WELTER, A ;
HEITHECKER, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (06) :1816-1821
[20]   Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure [J].
Oelkers, WKH .
STEROIDS, 1996, 61 (04) :166-171